May & Baker, a listed pharmaceutical company, has reported N1.1 billion in profit for the first quarter of 2025, a 74 percent increase from the N655 million reported in the same period of the previous year.
According to BusinessDay’s analysis of the company’s Q1 financial results, the company recorded revenue of N9.5 billion, a 48 percent increase from the N6.4 million recorded in March 2024.
In its financials, May and Baker disclosed that it made the highest amount (N3.11 billion) in Lagos, N3.1 billion in the East, N2 billion in the West and N1.2 billion in the North.